ATE295149T1 - Zubereitungen mit olopatadin zur topischen anwendung - Google Patents

Zubereitungen mit olopatadin zur topischen anwendung

Info

Publication number
ATE295149T1
ATE295149T1 AT02737539T AT02737539T ATE295149T1 AT E295149 T1 ATE295149 T1 AT E295149T1 AT 02737539 T AT02737539 T AT 02737539T AT 02737539 T AT02737539 T AT 02737539T AT E295149 T1 ATE295149 T1 AT E295149T1
Authority
AT
Austria
Prior art keywords
olopatadine
preparations
topical use
topical
Prior art date
Application number
AT02737539T
Other languages
English (en)
Inventor
Ernesto J Castillo
Wesley Wehsin Han
Huixiang Zhang
Haresh G Bhagat
Onkar N Singh
Joseph Paul Bullock
Suresh C Dixit
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23162841&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE295149(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE295149T1 publication Critical patent/ATE295149T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02737539T 2001-06-27 2002-06-19 Zubereitungen mit olopatadin zur topischen anwendung ATE295149T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30131501P 2001-06-27 2001-06-27
PCT/US2002/019417 WO2003002093A1 (en) 2001-06-27 2002-06-19 Olopatadine formulations for topical administration

Publications (1)

Publication Number Publication Date
ATE295149T1 true ATE295149T1 (de) 2005-05-15

Family

ID=23162841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02737539T ATE295149T1 (de) 2001-06-27 2002-06-19 Zubereitungen mit olopatadin zur topischen anwendung

Country Status (21)

Country Link
US (2) US6995186B2 (de)
EP (1) EP1399127B1 (de)
JP (5) JP4827374B2 (de)
KR (1) KR100884711B1 (de)
CN (1) CN1211125C (de)
AR (1) AR034619A1 (de)
AT (1) ATE295149T1 (de)
AU (1) AU2002310461B2 (de)
BR (1) BRPI0210707B8 (de)
CA (1) CA2447924C (de)
DE (1) DE60204142T2 (de)
DK (1) DK1399127T3 (de)
ES (1) ES2238574T3 (de)
GC (1) GC0000397A (de)
HK (1) HK1059573A1 (de)
MX (1) MXPA03011947A (de)
PL (1) PL205565B1 (de)
PT (1) PT1399127E (de)
TW (1) TWI231759B (de)
WO (1) WO2003002093A1 (de)
ZA (1) ZA200308771B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090235933A1 (en) * 2008-08-26 2009-09-24 Trutek Corp. Electrostatically charged mask filter products and method for increased filtration efficiency
US20100055152A1 (en) * 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US20050209312A1 (en) * 2004-03-19 2005-09-22 Bausch & Lomb Incorporated Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative
KR101252863B1 (ko) * 2004-04-08 2013-04-09 교와 핫꼬 기린 가부시키가이샤 안정성이 향상된 고형 제제 및 그 제조 방법
KR20070001232A (ko) * 2004-04-21 2007-01-03 교와 핫꼬 고교 가부시끼가이샤 만성 부비강염의 예방 및/또는 치료제
US20050288283A1 (en) * 2004-06-28 2005-12-29 Alcon, Inc. Topical formulations for treating allergic diseases
CN103860540A (zh) * 2004-11-24 2014-06-18 爱尔康公司 奥洛他定在治疗鼻子过敏或发炎状态的制剂制备中的用途
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
ES2437077T3 (es) 2005-07-08 2014-01-08 Senju Pharmaceutical Co., Ltd. Preparado oftálmico de absorción percutánea que comprende olopatadina
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
AR063621A1 (es) 2006-11-09 2009-02-04 Alcon Res Ltd Matriz polimerica insoluble en agua para la administracion de farmacos
US20080114076A1 (en) * 2006-11-09 2008-05-15 Alcon Manufacturing Ltd. Punctal plug comprising a water-insoluble polymeric matrix
TW200829293A (en) * 2006-12-18 2008-07-16 Alcon Mfg Ltd Devices and methods for ophthalmic drug delivery
WO2008093358A2 (en) * 2007-01-29 2008-08-07 Sun Pharmaceutical Industries Limited Aqueous topical solution containing olopatadine
ES2781090T3 (es) * 2007-02-07 2020-08-28 Novartis Ag Formulaciones de olopatadina para administración nasal tópica
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
JP2010523695A (ja) * 2007-04-11 2010-07-15 アルコン リサーチ， リミテッド アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのＴＮＦαのインヒビターおよび抗ヒスタミン薬の使用
US20100227917A1 (en) * 2007-09-06 2010-09-09 Masashi Nakakura EYE DROP CONTAINING DIBENZ[b,e]OXEPIN DERIVATIVE
CA2723954A1 (en) * 2008-05-19 2009-11-26 Alcon Research, Ltd. Pharmaceutical compositions having carboxyvinyl polymer and povidone polymer
KR20110056526A (ko) * 2008-08-28 2011-05-30 트루텍 코프. 항히스타민 및 유사-항히스타민 코 외용약, 생성물 및 방법
US9458198B1 (en) 2009-06-26 2016-10-04 Shire Orphan Therapies Gmbh Cyclic peptide-based NPR-B agonists
MX2012000539A (es) * 2009-07-17 2012-02-28 Alcon Res Ltd Regimen de rocio nasal de olopatadina para niños.
WO2011027322A1 (en) * 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
US8551938B2 (en) * 2009-09-25 2013-10-08 Alcon Research, Ltd. NPR-B agonists
KR101854820B1 (ko) 2009-09-25 2018-05-04 샤이어 오펀 테라피즈 게엠베하 신규한 ｎｐｒ－ｂ 길항제
MX2012003693A (es) * 2009-10-01 2012-04-19 Alcon Res Ltd Composiciones de olopatadine y usos de las mismas.
AR078446A1 (es) 2009-12-18 2011-11-09 Alcon Res Ltd Agonistas de npr-b. uso.
WO2011075471A2 (en) 2009-12-18 2011-06-23 Alcon Research, Ltd. Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders
JP2013535451A (ja) * 2010-07-21 2013-09-12 アルコン リサーチ， リミテッド 増強された溶解度特徴を有する薬学的組成物
AU2011327785A1 (en) * 2010-11-08 2013-03-07 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
CN102885767A (zh) * 2012-11-02 2013-01-23 江苏吉贝尔药业有限公司 一种新的盐酸奥洛他定滴眼液及其制备方法
EP3576770A1 (de) 2017-02-01 2019-12-11 Shire Human Genetic Therapies, Inc. Verbindungen und zusammensetzungen zur behandlung von augenkrankheiten
JP7037349B2 (ja) * 2017-06-23 2022-03-16 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
WO2018235935A1 (ja) * 2017-06-23 2018-12-27 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
CA3160570A1 (en) * 2019-12-06 2021-06-10 Taizou Kamishita Rhinenchysis composition containing olopatadine
CN111700860A (zh) * 2020-07-09 2020-09-25 浙江尖峰药业有限公司 盐酸奥洛他定滴眼液及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370324A (en) 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
US4407791A (en) * 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
DE3877904D1 (de) * 1987-11-13 1993-03-11 Asta Pharma Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
JP3662944B2 (ja) 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
WO1998056381A1 (en) * 1997-06-09 1998-12-17 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
KR100598723B1 (ko) 1998-07-14 2006-07-11 알콘 매뉴팩츄어링, 리미티드 비알레르기성 안염증 질환 치료 및 안혈관신생 예방용약제를 제조하기 위한11-(3-디메틸아미노프로필리덴)-6,11-디하이드로디벤즈[β,ε]옥세핀-2-아세트산의 용도
US6146622A (en) 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
PT1124535E (pt) * 1998-10-27 2003-04-30 Alcon Lab Inc Sistema conservante para composicoes farmaceuticas topicamente administraveis contendo um sabao de acido gordo/amino acido
US6274626B1 (en) * 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
US6174914B1 (en) * 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
PL354365A1 (en) 1999-09-21 2004-01-12 Alcon Laboratories, Inc. Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions
BR0015647A (pt) 1999-11-18 2002-07-16 Alcon Inc Uso de um antagonista de h1 e um esteróide seguro para tratar condições dos olhos
ATE291913T1 (de) 2000-01-25 2005-04-15 Alcon Inc Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
PE20020578A1 (es) 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
TWI231759B (en) 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
MXPA05005044A (es) 2002-11-12 2005-07-01 Alcon Inc El uso de un agente antialergico y un esteroide para tratar rinitis alergica.

Also Published As

Publication number Publication date
JP2004536096A (ja) 2004-12-02
DE60204142T2 (de) 2005-10-06
JP4827374B2 (ja) 2011-11-30
US6995186B2 (en) 2006-02-07
CN1211125C (zh) 2005-07-20
JP5328947B2 (ja) 2013-10-30
HK1059573A1 (en) 2004-07-09
ZA200308771B (en) 2005-01-26
BR0210707A (pt) 2004-07-20
GC0000397A (en) 2007-03-31
CA2447924C (en) 2009-11-03
JP2009114213A (ja) 2009-05-28
AU2002310461B2 (en) 2006-05-18
PL367780A1 (en) 2005-03-07
US20030055102A1 (en) 2003-03-20
US20050158387A1 (en) 2005-07-21
WO2003002093A1 (en) 2003-01-09
KR100884711B1 (ko) 2009-02-19
CA2447924A1 (en) 2003-01-09
EP1399127B1 (de) 2005-05-11
ES2238574T3 (es) 2005-09-01
DE60204142D1 (de) 2005-06-16
CN1525849A (zh) 2004-09-01
KR20040025919A (ko) 2004-03-26
BRPI0210707B8 (pt) 2021-05-25
PT1399127E (pt) 2005-07-29
AR034619A1 (es) 2004-03-03
US7402609B2 (en) 2008-07-22
TWI231759B (en) 2005-05-01
JP2010150292A (ja) 2010-07-08
BRPI0210707B1 (pt) 2015-08-04
JP2012107046A (ja) 2012-06-07
PL205565B1 (pl) 2010-05-31
MXPA03011947A (es) 2004-03-26
EP1399127A1 (de) 2004-03-24
JP2013127005A (ja) 2013-06-27
DK1399127T3 (da) 2005-06-13

Similar Documents

Publication Publication Date Title
ATE295149T1 (de) Zubereitungen mit olopatadin zur topischen anwendung
ATA1472001A (de) Beregnungsanlage
DE60210289D1 (de) Atemerfrischender film
IS7268A (is) Efnafræðilega breytt samtengd mennsk vaxtarhormón
NO20023616D0 (no) Ny anvendelse
DE60139468D1 (de) Motorsteuerung
DE60216469D1 (de) Lichtpolarisierender film mit melanin
DK1333853T3 (da) Vækstfaktorkompleks
ATE267429T1 (de) Übereinstimmungssteuerverfahren
DE60140443D1 (de) Motorsteuerung
DE60217545D1 (de) Spritzvorrichtung mit seitlicher betätigung
DE50205853D1 (de) Drosselklappenstutzen
DE60119758D1 (de) Verbundsegment
DE60238111D1 (de) Viszeralfettmesser mit tonometer
DE50211643D1 (de) s Einspritzventils
ATE387204T1 (de) Zusammensetzung mit induzierendem kathartischen effekt
DE60143148D1 (de) En mit honigwaben
DE60237780D1 (de) Motorsteuerung
DE50207870D1 (de) Abschlussbandage
DE60234481D1 (de) Verschachtelungsverfahren
DE60126125D1 (de) Neue carbapenem-derivate
DE60217710D1 (de) Neue formulierung
DE50105234D1 (de) Ventileinrichtung
DE50104708D1 (de) Wegeventil
NO20026215D0 (no) Nytt hormonpreparat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1399127

Country of ref document: EP